首页> 外文期刊>Advances in Natural Sciences: Nanoscience and Nanotechnology >Evaluation of anti-HER2 scFv-conjugated PLGA–PEG nanoparticles on 3D tumor spheroids of BT474 and HCT116 cancer cells - IOPscience
【24h】

Evaluation of anti-HER2 scFv-conjugated PLGA–PEG nanoparticles on 3D tumor spheroids of BT474 and HCT116 cancer cells - IOPscience

机译:抗HER2 scFv偶联的PLGA-PEG纳米颗粒对BT474和HCT116癌细胞的3D肿瘤球体的评估-IOPscience

获取原文
获取外文期刊封面目录资料

摘要

Three-dimensional culture cells (spheroids) are one of the multicellular culture models that can be applied to anticancer chemotherapeutic development. Multicellular spheroids more closely mimic in vivo tumor-like patterns of physiologic environment and morphology. In previous research, we designed docetaxel-loaded pegylated poly(D, L-lactide-co-glycolide) nanoparticles conjugated with anti-HER2 single chain antibodies (scFv–Doc–PLGA–PEG) and evaluated them in 2D cell culture. In this study, we continuously evaluate the cellular uptake and cytotoxic effect of scFv–Doc–PLGA–PEG on a 3D tumor spheroid model of BT474 (HER2-overexpressing) and HCT116 (HER2-underexpressing) cancer cells. The results showed that the nanoparticle formulation conjugated with scFv had a significant internalization effect on the spheroids of HER2-overexpressing cancer cells as compared to the spheroids of HER2-underexpressing cancer cells. Therefore, cytotoxic effects of targeted nanoparticles decreased the size and increased necrotic score of HER2-overexpressing tumor spheroids. Thus, these scFv–Doc–PLGA–PEG nanoparticles have potential for active targeting for HER2-overexpressing cancer therapy. In addition, BT474 and HCT116 spheroids can be used as a tumor model for evaluation of targeting therapies.
机译:三维培养细胞(球体)是可用于抗癌化学疗法开发的多细胞培养模型之一。多细胞球体更接近地模仿体内肿瘤样的生理环境和形态。在先前的研究中,我们设计了多西他赛负载的聚乙二醇化聚(D,L-丙交酯-乙交酯)纳米颗粒与抗-HER2单链抗体(scFv–Doc–PLGA–PEG)的结合,并在二维细胞培养中对其进行了评估。在这项研究中,我们持续评估scFv–Doc–PLGA–PEG对BT474(HER2过表达)和HCT116(HER2过表达)癌细胞的3D肿瘤球体模型的细胞摄取和细胞毒性作用。结果显示,与表达不足HER2的癌细胞的球体相比,与scFv缀合的纳米颗粒制剂对过表达HER2的癌细胞的球体具有显着的内在化作用。因此,靶向纳米颗粒的细胞毒性作用降低了过表达HER2的肿瘤球体的大小,并增加了其坏死分数。因此,这些scFv–Doc–PLGA–PEG纳米粒子具有潜在的主动靶向作用,用于过度表达HER2的癌症治疗。另外,BT474和HCT116球体可以用作评估靶向治疗的肿瘤模型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号